产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 24008 | RNK-05047 | 2503036-46-0 | ≧98.0% |  |
| RNK-05047 为BRD4降解剂，其在小鼠荷瘤异种移植模型中展现出显著抑 | ||||
| 20655 | (R)-Praziquantel | 57452-98-9 | 98% Min. | -Praziquantel_57452-98-9.png) |
| (R)-Praziquantel is an active enantiomer of praziquantel that acts as a potent anthel | ||||
| 20652 | Resminostat | 864814-88-0 | 98% Min. |  |
| Resminostat, also known as 4S-201 and RAS2410, is an orally bioavailable inhibitor of | ||||
| 20627 | Resigratinib | 2750709-91-0 | 98% Min. |  |
| Resigratinib is a fibroblast growth factor receptor tyrosine kinase inhibitor and ant | ||||
| 20621 | Risvodetinib | 2031185-00-7 | 98% Min. |  |
| Risvodetinib, also known as IkT-148009., is a brain-penetrant c-Abl inhibitor with a | ||||
| 20595 | Ropidoxuridine | 93265-81-7 | 98% Min. |  |
| Ropidoxuridine is a novel, orally available, thymidine analogue and prodrug for IUdR, | ||||
| 20526 | RPT193 | 2366152-15-8 | 98% Min. |  |
| 230403 | (R,S)-BI 1015550 | 1423719-27-0 | ≧98.0% | -BI_1015550_1423719-27-0.png) |
| BI 1015550 is a novel PDE4 inhibitor showing a preferential enzymatic inhibition of P | ||||
| 233901 | RRX-001 | 925206-65-1 | ≧98.0% |  |
| RRx-001 是一种高选择性 NLRP3 抑制剂，具有血管正常化和肿瘤相关的 | ||||
| 20460 | Ro5-3335 | 30195-30-3 | ≧98.0% |  |
| Ro5-3335 是一种亲脂性小分子 RUNX1 抑制剂。 | ||||
| 20452 | Ritlecitinib tosylate | 2192215-81-7 | 98% Min. |  |
| Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF | ||||
| 2320201 | Ro 24-7429 | 139339-45-0 | ≧98.0% |  |
| Ro24-7429是一种有效的口服活性HIV-1 反式激活蛋白Tat 拮抗剂和一种 | ||||
| 822224 | 布瑞拉沙秦（Brilaroxazine） | 1239729-06-6 | ≧98.0% |  |
| RP-5063（Brilaroxazine） 是一种多模式的血清素和多巴胺受体调节剂， | ||||
| 20316 | Rucaparib Camsylate | 1859053-21-6 | 98% Min. |  |
| Rucaparib camsylate is a potent, orally available inhibitor of poly ADP-ribose polyme | ||||
| 21235 | Rhosin hydrochloride | 1281870-42-5 | 98% Min. |  |
| 20123102 | (R,Z)-1-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino) quinazolin-6-yl)but-2-yn-1-one O-morpholin-3-ylmethyl oxime | 1831116-75-6 | 98% Min. |  |
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||
| 20102901 | Razuprotafib | 1008510-37-9 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||
| 2073103 | Remibrutinib ( LOU064 ) | 1787294-07-8 | 98% Min. | .png) |
| Remibrutinib ( LOU064 ) is a Potent and Highly Selective Covalent Inhibitor of Bruton | ||||
| 2071545 | Remdesivir | 1809249-37-3 | 98% Min. |  |
| Remdesivir, also known as GS-5734, is a prodrug form of the antiviral nucleoside anal | ||||
| 2071520 | RK-287107 | 2171386-10-8 | 98% Min. |  |
| RK-287107 is a potent TNKS/TNKS2 inhibitor (IC50 = 14.4 nM) with >7000-fold select | ||||
| 207101 | RBN-2397 | 2381037-82-5 | 98% Min. |  |
| 2062334 | (2R,6S)-tert-butyl 4-(4-aminobenzoyl)-2,6-dimethylpiperazine-1-carboxylate | 2161337-98-8 | 98% Min. |  |
| 202329 | (R)-methyl 2-(tert-butyldimethylsilyloxy)propanoate | 171230-81-2 | 98% Min. |  |
| 2062017 | 3-[(2RS)-tetrahydro-2H-pyran-2-yloxy]propanoic acid | 1221443-23-7 | 96% Min. | -tetrahydro-2H-pyran-2-yloxy]propanoic_acid_1221443-23-7.png) |
| 2062004 | [(1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl]-methyl acetate | 1369768-29-5 | ≧95.0% | -2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl)methyl_acetate_1369768-29-5.gif) |
| 690120 | Rigosertib | 592542-59-1 | 98% Min. |  |
| Rigosertib(ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, w | ||||
| 206102 | Resatorvid | 243984-11-4 | 98% Min. |  |
| Resatorvid, also known as TAK-242, is a cell-permeable inhibitor of TLR4 signaling, b | ||||
| 204503 | RU320521 | 2262452-06-0 | 98% Min. |  |
| RU320521, also known as RU521; RU.521 is a potent and selective inhibitor of cGAS, in | ||||
| 580586 | (2R)-2-乙炔-2-甲基-1-吡咯烷乙酸 1,1-二甲基乙酯 | 2086689-88-3 | >96% |  |
| (2R)-2-乙炔-2-甲基-1-吡咯烷乙酸 1,1-二甲基乙酯 是 Pamiparib合成中一 | ||||